Literature DB >> 12883857

A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation.

Ivar Østby1, Leiv S Rusten, Gunnar Kvalheim, Per Grøttum.   

Abstract

High dose chemotherapy supported with hematopoietic progenitor cells gives a characteristic neutropenic period (blood neutrophils < 0.5 x 10(9) c/l) ranging from 10 to 16 days. The question of a correlation between the CFU-GM content of the transplanted CD34+ cells and time to neutrophil recovery by patients having been given high-dose chemotherapy (HD-CT) with stem cell support was addressed by means of a mathematical model of granulopoiesis. The model utilizes a convection-reaction partial differential equation (PDE) with feedback from a cytokine compartment on proliferation, maturation, and mobilization of granulocytes from bone marrow to blood. The observed number of CFU-GM cells in the transplanted CD34+ cell autograft was used as input to the model. Using this approach, the observed gross relationship between CFU-GM content in the reinfused blood product and engraftment time could be reproduced. At the same time, the effects of assumed physiological mechanisms, especially some of the effects of G-CSF on proliferation rate, maturation rate, mobilization, and cell death, could be investigated and discussed relative to observed engraftment. The model makes it possible to explain how cytokines interfere with progenitor cell mobilization from bone marrow to blood, and it points out the implications of a regulating mechanism for the granulocyte maturation rate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12883857     DOI: 10.1007/s00285-003-0198-6

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  69 in total

1.  Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.

Authors:  E Aurlien; H Holte; A Pharo; S Kvaløy; E Jakobsen; E B Smeland; G Kvalheim
Journal:  Bone Marrow Transplant       Date:  1998-05       Impact factor: 5.483

2.  Cell-dose effect in circulating stem-cell autografting.

Authors:  L B To; P G Dyson; C A Juttner
Journal:  Lancet       Date:  1986-08-16       Impact factor: 79.321

3.  Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.

Authors:  M Bhatia; J C Wang; U Kapp; D Bonnet; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Model analysis of the contrasting effects of GM-CSF and G-CSF treatment on peripheral blood neutrophils observed in three patients with childhood-onset cyclic neutropenia.

Authors:  S Schmitz; H Franke; M Loeffler; H E Wichmann; V Diehl
Journal:  Br J Haematol       Date:  1996-12       Impact factor: 6.998

5.  Maturation rate of mouse neutrophilic granulocytes: acceleration by retardation of proliferation, but no detectable influence from G-CSF or stromal cells.

Authors:  X Wang; H Fjerdingstad; I Strøm-Gundersen; H B Benestad
Journal:  Stem Cells       Date:  1999       Impact factor: 6.277

6.  Serum granulocyte colony-stimulating factor kinetics in children receiving intense chemotherapy with or without stem cell support.

Authors:  S Saito; Y Kawano; T Watanabe; Y Okamoto; T Abe; Y Kurada; Y Takaue
Journal:  J Hematother       Date:  1999-06

7.  Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.

Authors:  G Baiocchi; G Scambia; P Benedetti; G Menichella; U Testa; L Pierelli; R Martucci; M L Foddai; B Bizzi; S Mancuso
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

8.  The effect of continuous G-CSF application in human cyclic neutropenia: a model analysis.

Authors:  S Schmitz; H Franke; H E Wichmann; V Diehl
Journal:  Br J Haematol       Date:  1995-05       Impact factor: 6.998

9.  Expression and dynamic modulation of the human granulocyte colony-stimulating factor receptor in immature and differentiated myeloid cells.

Authors:  A Khwaja; J Carver; H M Jones; D Paterson; D C Linch
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

10.  Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children.

Authors:  N Stute; V M Santana; J H Rodman; M J Schell; J N Ihle; W E Evans
Journal:  Blood       Date:  1992-06-01       Impact factor: 22.113

View more
  14 in total

1.  Stability of a model of human granulopoiesis using continuous maturation.

Authors:  Ivar Østby; Ragnar Winther
Journal:  J Math Biol       Date:  2004-07-05       Impact factor: 2.259

2.  Simulating mouse mammary gland development: cell ageing and its relation to stem and progenitor activity.

Authors:  A Paguirigan; D J Beebe; C M Alexander
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

3.  Modelling human granulopoiesis under poly-chemotherapy with G-CSF support.

Authors:  M Scholz; C Engel; M Loeffler
Journal:  J Math Biol       Date:  2004-12-20       Impact factor: 2.259

Review 4.  Dynamic hematological disease: a review.

Authors:  Catherine Foley; Michael C Mackey
Journal:  J Math Biol       Date:  2008-03-04       Impact factor: 2.259

5.  Personalising docetaxel and G-CSF schedules in cancer patients by a clinically validated computational model.

Authors:  O Vainas; S Ariad; O Amir; W Mermershtain; V Vainstein; M Kleiman; O Inbar; R Ben-Av; A Mukherjee; S Chan; Z Agur
Journal:  Br J Cancer       Date:  2012-07-19       Impact factor: 7.640

6.  Modelling chemotherapy effects on granulopoiesis.

Authors:  Sibylle Schirm; Christoph Engel; Markus Loeffler; Markus Scholz
Journal:  BMC Syst Biol       Date:  2014-12-24

7.  Mathematical modeling reveals differential effects of erythropoietin on proliferation and lineage commitment of human hematopoietic progenitors in early erythroid culture.

Authors:  Daniel Ward; Deborah Carter; Martin Homer; Lucia Marucci; Alexandra Gampel
Journal:  Haematologica       Date:  2015-11-20       Impact factor: 9.941

8.  Parameter identification of hematopoiesis mathematical model - periodic chronic myelogenous leukemia.

Authors:  Anahita Safarishahrbijari; Ali Gaffari
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15

9.  Pharmacokinetic and -dynamic modelling of G-CSF derivatives in humans.

Authors:  Markus Scholz; Sibylle Schirm; Marcus Wetzler; Christoph Engel; Markus Loeffler
Journal:  Theor Biol Med Model       Date:  2012-07-30       Impact factor: 2.432

10.  A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment.

Authors:  Sibylle Schirm; Christoph Engel; Markus Loeffler; Markus Scholz
Journal:  Theor Biol Med Model       Date:  2014-05-26       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.